The trademark application was filed by Santen Pharmaceutical Co., Ltd., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on March 18, 2020, and it was registered by office on June 26, 2020 without any oppositions.
The application was filed in Finnish (English was selected as the second language).
Change of name and address of the trademark registration was recorded on March 24, 2020.